Melissa Faris

764 total citations
17 papers, 569 citations indexed

About

Melissa Faris is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Immunology and Allergy. According to data from OpenAlex, Melissa Faris has authored 17 papers receiving a total of 569 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Pulmonary and Respiratory Medicine, 13 papers in Physiology and 10 papers in Immunology and Allergy. Recurrent topics in Melissa Faris's work include Asthma and respiratory diseases (13 papers), Allergic Rhinitis and Sensitization (10 papers) and Respiratory and Cough-Related Research (8 papers). Melissa Faris is often cited by papers focused on Asthma and respiratory diseases (13 papers), Allergic Rhinitis and Sensitization (10 papers) and Respiratory and Cough-Related Research (8 papers). Melissa Faris collaborates with scholars based in United States, United Kingdom and Chile. Melissa Faris's co-authors include E. Philpot, Kathleen Rickard, Paul H. Ratner, Wytske J. Fokkens, Barbara A. Prillaman, Wei Wu, Frank C. Hampel, Charles P. Andrews, David B. Allen and Eli O. Meltzer and has published in prestigious journals such as CHEST Journal, Journal of Allergy and Clinical Immunology and Allergy.

In The Last Decade

Melissa Faris

17 papers receiving 545 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Melissa Faris United States 12 491 411 220 105 55 17 569
Andrea Buchmeier United States 9 489 1.0× 489 1.2× 237 1.1× 30 0.3× 181 3.3× 13 631
G. K. Scadding Belgium 4 474 1.0× 509 1.2× 120 0.5× 120 1.1× 137 2.5× 5 569
H Grønborg Denmark 8 222 0.5× 210 0.5× 75 0.3× 33 0.3× 52 0.9× 14 322
M T Dordal Spain 10 260 0.5× 285 0.7× 67 0.3× 29 0.3× 116 2.1× 24 416
Rodrigo Baena-Cagnani Italy 6 318 0.6× 330 0.8× 90 0.4× 22 0.2× 143 2.6× 7 396
S. M. Nasser United Kingdom 8 173 0.4× 278 0.7× 41 0.2× 36 0.3× 88 1.6× 9 382
Elisabeth Pfrogner Germany 10 251 0.5× 244 0.6× 44 0.2× 30 0.3× 53 1.0× 18 342
M C Sánchez Spain 8 240 0.5× 309 0.8× 44 0.2× 28 0.3× 114 2.1× 11 362
Hosne Ara Ferdousi Sweden 7 1.6k 3.2× 1.6k 3.9× 357 1.6× 71 0.7× 766 13.9× 8 1.7k
Christian Ljørring Denmark 7 824 1.7× 826 2.0× 219 1.0× 19 0.2× 388 7.1× 12 941

Countries citing papers authored by Melissa Faris

Since Specialization
Citations

This map shows the geographic impact of Melissa Faris's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Melissa Faris with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Melissa Faris more than expected).

Fields of papers citing papers by Melissa Faris

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Melissa Faris. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Melissa Faris. The network helps show where Melissa Faris may publish in the future.

Co-authorship network of co-authors of Melissa Faris

This figure shows the co-authorship network connecting the top 25 collaborators of Melissa Faris. A scholar is included among the top collaborators of Melissa Faris based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Melissa Faris. Melissa Faris is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Patel, Deepen, et al.. (2008). Lack of effect on adult and adolescent hypothalamic-pituitary-adrenal axis function with use of fluticasone furoate nasal spray. Annals of Allergy Asthma & Immunology. 100(5). 490–496. 19 indexed citations
2.
Fokkens, Wytske J., Rain Jögi, S.M. Reinartz, et al.. (2007). Once daily fluticasone furoate nasal spray is effective in seasonal allergic rhinitis caused by grass pollen. Allergy. 62(9). 1078–1084. 85 indexed citations
3.
Rosenblüt, Andrés, et al.. (2007). Long‐term safety of fluticasone furoate nasal spray in adults and adolescents with perennial allergic rhinitis. Allergy. 62(9). 1071–1077. 66 indexed citations
4.
Ratner, Paul H., Frank C. Hampel, Charles P. Andrews, et al.. (2007). Optimal dose selection of fluticasone furoate nasal spray for the treatment of seasonal allergic rhinitis in adults and adolescents. Allergy and Asthma Proceedings. 28(2). 216–225. 64 indexed citations
5.
6.
7.
Nathan, R.A., William E. Berger, W.H. Yang, et al.. (2007). Once Daily Fluticasone Furoate∗ Nasal Spray (FFNS), a Novel Enhanced Affinity Steroid, Provides 24-hour Relief for the Nasal Symptoms of Perennial Allergic Rhinitis (PAR). Journal of Allergy and Clinical Immunology. 119(1). S65–S65. 4 indexed citations
8.
Andrews, Charles P., et al.. (2006). Comparison of fluticasone propionate aqueous nasal spray and oral montelukast for the treatment of seasonal allergic rhinitis symptoms. Annals of Allergy Asthma & Immunology. 96(6). 851–857. 40 indexed citations
9.
Wasserman, Richard L., James Baker, Kathryn Blake, et al.. (2006). Efficacy and safety of inhaled fluticasone propionate chlorofluorocarbon in 2- to 4-year-old patients with asthma: results of a double-blind, placebo-controlled study. Annals of Allergy Asthma & Immunology. 96(6). 808–818. 34 indexed citations
10.
Sheth, Ketan, Cindy K. Cook, E. Philpot, et al.. (2004). Concurrent use of intranasal and orally inhaled fluticasone propionate does not affect hypothalamic-pituitary-adrenal-axis function.. PubMed. 25(2). 115–20. 16 indexed citations
11.
12.
Ratner, Paul H., William C. Howland, E. Philpot, et al.. (2003). Fluticasone propionate aqueous nasal spray provided significantly greater improvement in daytime and nighttime nasal symptoms of seasonal allergic rhinitis compared with montelukast. Annals of Allergy Asthma & Immunology. 90(5). 536–542. 61 indexed citations
13.
Allen, David B., Eli O. Meltzer, Robert F. Lemanske, et al.. (2003). No growth suppression in children treated with the maximum recommended dose of fluticasone propionate aqueous nasal spray for one year.. PubMed. 23(6). 407–13. 92 indexed citations
14.
Hawksworth, Richard J., A.P. Sykes, Melissa Faris, Tim Mant, & TH Lee. (2002). Albuterol HFA is as effective as albuterol CFC in preventing exercise-induced bronchoconstriction. Annals of Allergy Asthma & Immunology. 88(5). 473–477. 16 indexed citations
15.
16.
O’Riordan, Thomas G. & Melissa Faris. (1999). Inhaled antimicrobial therapy.. PubMed. 5(4). 617–31. 14 indexed citations
17.
Faris, Melissa, Ralph H. Raasch, Roy L. Hopfer, & John D. Butts. (1998). Treatment and Prophylaxis of Disseminated Mycobacterium Avium Complex in HIV-Infected Individuals. Annals of Pharmacotherapy. 32(5). 564–573. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Andrea Buchmeier Breakdown of academic impact, for papers by G. K. Scadding Breakdown of academic impact, for papers by H Grønborg Breakdown of academic impact, for papers by M T Dordal Breakdown of academic impact, for papers by Rodrigo Baena-Cagnani Breakdown of academic impact, for papers by S. M. Nasser Breakdown of academic impact, for papers by Elisabeth Pfrogner Breakdown of academic impact, for papers by M C Sánchez Breakdown of academic impact, for papers by Hosne Ara Ferdousi Breakdown of academic impact, for papers by Christian Ljørring
Rankless by CCL
2026